No Advantages in the Addition of Ifosfamide and VP-16 to the Standard Four-Drug Regimen in the Maintenance Phase of Neoadjuvant Chemotherapy of Ewing’s Sarcoma of Bone: Results of Two Sequential Studies
Bacci, G., Picci, P., Ruggieri, P., Ferrari, S., Mercuri, M., Fabbri, N., Rosito, P., Barbieri, E., Ferraro, A., Casadei, R., Brach Del Prever, A., Tienghi, A., Cazzola, A., Campanacci, MVolume:
5
Language:
english
Journal:
Journal of Chemotherapy
DOI:
10.1080/1120009x.1993.11739240
Date:
August, 1993
File:
PDF, 8.10 MB
english, 1993